Isse Pharmacy Services
Long Term Care Pharmacy
15635 Se 114th Ave Ste 101, Clackamas
Oregon, 97015-9028
503-908-0630 503-908-0865
Isse Pharmacy Services is an authorized DME supplier for medicare equipments and products.
Isse Pharmacy Services is a Long Term Care Pharmacy in Clackamas, Oregon. It is located at 15635 Se 114th Ave Ste 101, Clackamas and it's customer support contact number is 503-908-0630. The authorized person of Isse Pharmacy Services is Dr. Jared Isse, PHARMD who is Owner/pharmacist of the pharmacy and his contact number is 503-908-0630. Active license number of Isse Pharmacy Services is RP-0002831 for Long Term Care Pharmacy in Oregon. Isse Pharmacy Services accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance.
Isse Pharmacy Services is a pharmacy that dispenses medicinal preparations delivered to patients residing within an intermediate or skilled nursing facility, including intermediate care facilities for mentally retarded, hospice, assisted living facilities, group homes, and other forms of congregate living arrangements.
Pharmacy Details:
Isse Pharmacy Services type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
| Name: | Isse Pharmacy Services |
| Type: | Long Term Care Pharmacy |
| Location: | 15635 Se 114th Ave Ste 101, Clackamas, Oregon, 97015-9028 |
| Phone: | 503-908-0630 |
| Fax: | 503-908-0865 |
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
| Name: | Dr. Jared Isse |
| Credentials: | PHARMD |
| Position: | Owner/pharmacist |
| Contact Number: | 503-908-0630 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
| NPI Number: | 1225464118 |
| NPI Enumeration Date: | 24 Sep, 2013 |
| NPI Last Update On: | 13 Mar, 2020 |
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Isse Pharmacy Services are as mentioned below.
| Specialization | License Number | State | Status | |
| Long Term Care Pharmacy | RP-0002831 | Oregon | Primary | |
| Durable Medical Equipment & Medical Supplies | | | Secondary | |
| Pharmacy | | | Secondary | |
| Community/Retail Pharmacy | | | Secondary | |
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
| Identifier | Type | State | Issuer |
| 2142223 | Other | | Pk |
| 500667941 | Medicaid | Oregon | |
Medicare Enrollment:
Isse Pharmacy Services is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
| PAC ID: |
Enrollment ID: |
Org Name | Medicare Entity Type |
| 1254560840 | O20140130001056 | Jared Anthony Isse | PART B SUPPLIER - MASS IMMUNIZATION (ROSTER BILLER ONLY) |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 15635 Se 114th Ave Ste 101, Clackamas, Oregon |
| Zip: | 97015-9028 |
| Phone Number: | 503-908-0630 |
| Fax Number: | 503-908-0865 |
Patients can reach Isse Pharmacy Services at
15635 Se 114th Ave Ste 101, Clackamas, Oregon or can
call on customer care at 503-908-0630.
Comments/ Reviews:
Read all the reviews posted for Isse Pharmacy Services below. You may also share your own experience with Isse Pharmacy Services. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.